Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thrombosis Research|October 10, 2023
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation studyMilou A M Stals, Ludo F M Beenen, Michiel Coppens, et al.
Hemasphere|September 21, 2023
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, et al.
Blood|September 15, 2018
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinibIris de Weerdt, Tom Hofland, Roeland Lameris, et al.
Thrombosis Research|February 3, 2024
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trialSérine Chaibi, Pierre-Marie Roy, Armelle Arnoux Guénégou, et al.
Circulation|August 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled TrialLinda P T Joosten, Sander van Doorn, Peter M van de Ven, et al.
Thrombosis and Haemostasis|June 29, 2020
Reasons for Hospitalization of Patients with Acute Pulmonary Embolism Based on the Hestia Decision RuleStephan V Hendriks, Paul L den Exter, Wendy Zondag, et al.
Research and Practice in Thrombosis and Haemostasis|February 4, 2021
Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA studyEva N Hamulyák, Hanke M G Wiegers, Luuk J J Scheres, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2016
Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical TrialPaul L den Exter, Wendy Zondag, Frederikus A Klok, et al.
Journal of Thrombosis and Haemostasis : JTH|October 10, 2025
Sex differences in outcomes of vitamin K antagonist treatment in patients with a mechanical heart valve: a Dutch population-based cohort studyEva K Kempers, Chantal Visser, Jaap Seelig, et al.
Oncotarget|October 20, 2018
Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patientsLaurens E Franssen, Inger S Nijhof, Chad C Bjorklund, et al.
Pageof 3